203 related articles for article (PubMed ID: 28146080)
21. Coexistence of morphea and psoriasis responding to acitretin treatment.
Bilen N; Apaydin R; Erçin C; Harova G; Başdaş F; Bayramgürler D
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):113-7. PubMed ID: 10568490
[TBL] [Abstract][Full Text] [Related]
22. Acitretin for the treatment of psoriasis: an assessment of national trends.
Ghasri P; Yentzer BA; Dabade TS; Feldman SR
J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
[TBL] [Abstract][Full Text] [Related]
23. Combination of efalizumab and acitretin in chronic plaque psoriasis.
Gisondi P; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):247-8. PubMed ID: 18211428
[No Abstract] [Full Text] [Related]
24. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris.
Niu X; Cao W; Ma H; Feng J; Li X; Zhang X
J Dermatol; 2012 Nov; 39(11):916-21. PubMed ID: 22913391
[TBL] [Abstract][Full Text] [Related]
25. Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment.
Gerritsen MJ; van Pelt JP; van de Kerkhof PC
Acta Derm Venereol; 1996 Jan; 76(1):6-9. PubMed ID: 8721480
[TBL] [Abstract][Full Text] [Related]
26. Liraglutide in combination with acitretin for severe recalcitrant psoriasis.
Reid CT; Tobin AM; Ahern T; O'Shea D; Kirby B
Br J Dermatol; 2013 Jul; 169(1):230-1. PubMed ID: 23834125
[No Abstract] [Full Text] [Related]
27. Acitretin Use in Dermatology.
Guenther LC; Kunynetz R; Lynde CW; Sibbald RG; Toole J; Vender R; Zip C
J Cutan Med Surg; 2017; 21(3_suppl):2S-12S. PubMed ID: 28952335
[TBL] [Abstract][Full Text] [Related]
28. VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients.
Zhao Y; Chen X; Li J; He Y; Su J; Chen M; Zhang W; Chen W; Zhu W
J Dermatol Sci; 2015 Sep; 79(3):305-7. PubMed ID: 26169344
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin.
Werner B; Bresch M; Brenner FM; Lima HC
J Cutan Pathol; 2008 Mar; 35(3):302-10. PubMed ID: 18251745
[TBL] [Abstract][Full Text] [Related]
32. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
Janagond AB; Kanwar AJ; Handa S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
[TBL] [Abstract][Full Text] [Related]
34. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
[TBL] [Abstract][Full Text] [Related]
35. Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study.
Chularojanamontri L; Silpa-Archa N; Wongpraparut C; Limphoka P
Int J Dermatol; 2019 May; 58(5):593-599. PubMed ID: 30548592
[TBL] [Abstract][Full Text] [Related]
36. Complete and rapid regression of primary cutaneous follicular lymphoma with repeated oral administration of acitretin for palmoplantar psoriasis.
Khashoggi M; Samimi M; de Muret A; Machet L
J Am Acad Dermatol; 2013 Oct; 69(4):e176-7. PubMed ID: 24034386
[No Abstract] [Full Text] [Related]
37. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis.
Ezquerra GM; Regaña MS; Millet PU
Acta Derm Venereol; 2007; 87(5):449-50. PubMed ID: 17721663
[No Abstract] [Full Text] [Related]
38. Frizzled-related proteins 4 (SFRP4) rs1802073G allele predicts the elevated serum lipid levels during acitretin treatment in psoriatic patients from Hunan, China.
Zhou X; Zhu W; Shen M; He Y; Peng C; Kuang Y; Su J; Zhao S; Chen X; Chen W
PeerJ; 2018; 6():e4637. PubMed ID: 29666772
[TBL] [Abstract][Full Text] [Related]
39. Acitretin in dermatology: a review.
Dunn LK; Gaar LR; Yentzer BA; O'Neill JL; Feldman SR
J Drugs Dermatol; 2011 Jul; 10(7):772-82. PubMed ID: 21720660
[TBL] [Abstract][Full Text] [Related]
40. Acitretin revisited in the era of biologics.
Booij MT; Van De Kerkhof PC
J Dermatolog Treat; 2011 Apr; 22(2):86-9. PubMed ID: 20673152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
